Close Menu

In the early online edition of Genome Research this week, the University of Manchester's Andrew Sharrocks is lead author on a paper that used ChIP-chip to find all the target genes of the ETS-domain transcription factor ELK1. His team found that there are two modes by which ELK1 targets genes, and that one of the most "prominent groups of genes forming the ELK1 target network" are those that are part of the basal transcriptional machinery, the spliceosome, and the ribosome.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.